1. Home
  2. HAE vs WHD Comparison

HAE vs WHD Comparison

Compare HAE & WHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAE
  • WHD
  • Stock Information
  • Founded
  • HAE 1971
  • WHD 2011
  • Country
  • HAE United States
  • WHD United States
  • Employees
  • HAE N/A
  • WHD N/A
  • Industry
  • HAE Medical/Dental Instruments
  • WHD Metal Fabrications
  • Sector
  • HAE Health Care
  • WHD Industrials
  • Exchange
  • HAE Nasdaq
  • WHD Nasdaq
  • Market Cap
  • HAE 3.9B
  • WHD 3.8B
  • IPO Year
  • HAE 1991
  • WHD 2018
  • Fundamental
  • Price
  • HAE $73.49
  • WHD $63.64
  • Analyst Decision
  • HAE Strong Buy
  • WHD Hold
  • Analyst Count
  • HAE 9
  • WHD 6
  • Target Price
  • HAE $108.78
  • WHD $56.40
  • AVG Volume (30 Days)
  • HAE 513.7K
  • WHD 574.2K
  • Earning Date
  • HAE 02-06-2025
  • WHD 02-26-2025
  • Dividend Yield
  • HAE N/A
  • WHD 0.82%
  • EPS Growth
  • HAE N/A
  • WHD 21.87
  • EPS
  • HAE 2.41
  • WHD 2.84
  • Revenue
  • HAE $1,361,223,000.00
  • WHD $1,132,559,000.00
  • Revenue This Year
  • HAE $7.56
  • WHD $4.29
  • Revenue Next Year
  • HAE $3.13
  • WHD $3.23
  • P/E Ratio
  • HAE $30.49
  • WHD $22.42
  • Revenue Growth
  • HAE 9.84
  • WHD 12.15
  • 52 Week Low
  • HAE $69.29
  • WHD $38.15
  • 52 Week High
  • HAE $97.97
  • WHD $70.01
  • Technical
  • Relative Strength Index (RSI)
  • HAE 36.41
  • WHD 60.26
  • Support Level
  • HAE $69.29
  • WHD $58.57
  • Resistance Level
  • HAE $82.25
  • WHD $61.85
  • Average True Range (ATR)
  • HAE 2.96
  • WHD 1.76
  • MACD
  • HAE -0.32
  • WHD 0.76
  • Stochastic Oscillator
  • HAE 32.41
  • WHD 81.02

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control , which generates key revenue and Spoolable Technologies.

Share on Social Networks: